Clinical Trial Update: Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating buprenorphine/naloxone microdosing versus standard dosing in emergency department management of opioid-use disorder, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: University of British Columbia | Conditions: Opioid-use Disorder | Phase 2, Phase 3 | Status: RECRUITING